Hikma's Leucovorin Calcium ANDA072733 Receives Abbreviated Approval
Hikma has received an Abbreviated Approval (AP) for its ANDA072733 application for Leucovorin Calcium.
Therapeutic Area
Therapeutic area intelligence for Chemotherapy Support with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.